 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/14/2023 |
$152.01 |
$154.69 |
$151.80 |
$153.64 |
6.34M | | 09/15/2023 |
$152.78 |
$154.70 |
$151.93 |
$152.12 |
8.87M | | 09/18/2023 |
$153.08 |
$153.97 |
$152.10 |
$153.94 |
2.97M | | 09/19/2023 |
$153.89 |
$154.64 |
$151.60 |
$153.49 |
3.51M | | 09/20/2023 |
$154.06 |
$154.88 |
$153.37 |
$153.61 |
2.74M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on September 14, 2023, ABBV opened at $152.01, traded as high as $154.69 and as low as $151.80, and closed at $153.64. Trading volume was a total of 6.34M shares. On September 15, 2023, ABBV opened at $152.78, traded as high as $154.70 and as low as $151.93, and closed at $152.12. Trading volume was a total of 8.87M shares. On September 18, 2023, ABBV opened at $153.08, traded as high as $153.97 and as low as $152.10, and closed at $153.94. Trading volume was a total of 2.97M shares. On September 19, 2023, ABBV opened at $153.89, traded as high as $154.64 and as low as $151.60, and closed at $153.49. Trading volume was a total of 3.51M shares. On September 20, 2023, ABBV opened at $154.06, traded as high as $154.88 and as low as $153.37, and closed at $153.61. Trading volume was a total of 2.74M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
09/24/2013 |
|
| End date: |
09/20/2023 |
|
| Start price/share: |
$45.98 |
|
| End price/share: |
$153.61 |
|
| Starting shares: |
217.49 |
|
| Ending shares: |
327.63 |
|
| Dividends reinvested/share: |
$36.79 |
|
| Total return: |
403.27% |
|
| Average Annual Total Return: |
17.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$50,331.69 |
|
| Years: |
9.99 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/24/2013 |
|
| End date: |
09/20/2023 |
|
| Start price/share: |
$45.98 |
|
| End price/share: |
$153.61 |
|
| Dividends collected/share: |
$36.79 |
|
| Total return: |
314.09% |
|
| Average Annual Total Return: |
15.28% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$41,419.16 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 09/14/2023 | $153.64 | | 09/15/2023 | $152.12 | | 09/18/2023 | $153.94 | | 09/19/2023 | $153.49 | | 09/20/2023 | $153.61 |
|
|
Free ABBV Email Alerts:
